Influence of personality on the relationship between gray matter volume and neuropsychiatric symptoms in multiple sclerosis

Psychosomatic Medicine

Volumn 75, Issue 3, 2013, Pages 253-261

  Benedict, Ralph H B ^a   Schwartz, Carolyn E ^b,c   Duberstein, Paul ^d,e   Healy, Brian ^f   Hoogs, Marietta ^a   Bergsland, Niels ^a   Dwyer, Michael G ^a   Weinstock Guttman, Bianca ^a   Zivadinov, Robert ^a  

^a BUFFALO GENERAL HOSPITAL   (United States)

^b DeltaQuest Foundation Inc   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^e Rochester Health Decision Making Group   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

cognition; gray matter volume; multiple sclerosis; neuropsychiatric symptoms; personality

Indexed keywords

ADULT; ARTICLE; BRAIN SIZE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; EUPHORIA; FEMALE; GRAY MATTER; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROPSYCHIATRY; NEUROSCIENCE; NEUROSIS; PERSONALITY; PRIORITY JOURNAL; PSYCHOLOGIC TEST;

EID: 84876244039     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0b013e31828837cc     Document Type: Article

References (86)

1. Hauser SL, Oksenberg JR. The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration [review]. Neuron 2006;52:61-76.
2. Noonan CW, Williamson DM, Henry JP, Indian R, Lynch SG, Neuberger JS, Schiffer R, Trottier J, Wagner L, Marrie RA. The prevalence of multiple sclerosis in 3 US communities. Prev Chronic Dis 2010;7:A12.
3. Charcot JM. Lectures on the Diseases of the Nervous System. London: New Sydenham Society; 1877.
4. Finger S. A happy state of mind. Arch Neurol 1998;55:241-50.
5. Benedict R, Bobholz J. Multiple sclerosis. Semin Neurol 2007;27:78-86.
6. Benedict RHB, Carone D, Bakshi R. Correlating brain atrophy with cognitive dysfunction, mood disturbances, and personality disorder in multiple sclerosis. J Neuroimaging. 2004;14:36S-45S.
7. Fishman I, Benedict RH, Bakshi R, Priore R, Weinstock-Guttman B. Construct validity and frequency of euphoria sclerotica in multiple sclerosis. J Neuropsychiatry Clin Neurosci 2004;16:350-6.
8. Benedict RHB, Priore RL, Miller C, Munschauer F, Jacobs L. Personality disorder in multiple sclerosis correlates with cognitive impairment. J Neuropsychiatry Clin Neurosci 2001;13:70-6.
9. Rao SM, Leo GJ, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 1991;41:685-91.
10. Patten SB, Metz LM. Depression in multiple sclerosis. Psychother Psychosom 1999;66:286-92.
11. Benedict RHB, Cookfair D, Gavett R, Gunther M, Munschauer F, Garg N, Weinstock-Guttman B. Validity of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS). J Int Neuropsychol Soc 2006;12:549-58.
12. Benedict RHB, Wahlig E, Bakshi R, Fishman I, Munschauer F, Zivadinov R, Weinstock-Guttman B. Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change. J Neurol Sci 2005;23:29-34.
13. Benedict RHB, Shapiro A, Priore RL, Miller C, Munschauer FE, Jacobs LD. Neuropsychological counseling improves social behavior in cognitively-impaired multiple sclerosis patients. Mult Scler 2001;6:391-6.
14. Lane RD, Waldstein SR, Critchley HD, Derbyshire SW, Drossman DA, Wager TD, Schneiderman N, Chesney MA, Jennings JR, Lovallo WR, Rose RM, Thayer JF, Cameron OG. The rebirth of neuroscience in psychosomatic medicine, part II: clinical applications and implications for research. Psychosom Med 2009;71:135-51.
15. DeYoung CG, Hirsh JB, Shane MS, Papademetris X, Rajeevan N, Gray JR. Testing predictions from personality neuroscience. Brain structure and the big five. Psychol Sci 2010;21:820-8.
16. Zivadinov R, Sepcic J, Nasuelli D, De Masi R, Bragadin LM, Tommasi MA, Zambito-Marsala S, Moretti R, Bratina A, Ukmar M, Pozzi-Mucelli RS, Grop A, Cazzato G, Zorzon M. A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 2001;70:773-80.
17. Benedict RHB, Weinstock-Guttman B, Fishman I, Sharma J, Tjoa CW, Bakshi R. Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. Arch Neurol 2004;61:226-30.
18. Christodoulou C, Krupp LB, Liang Z, Huang W, Melville P, Roque C, Scherl WF, Morgan T, MacAllister WS, Li L, Tudorica LA, Li X, Roche P, Peyster R. Cognitive performance and MR markers of cerebral injury in cognitively impaired MS patients. Neurology 2003;60:1793-8.
19. Filippi M, Rocca MA, Benedict RH, DeLuca J, Geurts JJ, Rombouts SA, Ron M, Comi G. The contribution of MRI in assessing cognitive impairment in multiple sclerosis. Neurology 2010;75:2121-8.
20. Houtchens MK, Benedict RHB, Killiany R, Sharma J, Jaisani Z, Singh B, Weinstock-Guttman B, Guttmann CRG, Bakshi R. Thalamic atrophy and cognition in multiple sclerosis. Neurology 2007;69:113-23.
21. Roland G, Shieh M, Okuda DT, Evangelista A, Gorno-Tempini ML, Pelletier D. Regional grey matter atrophy in clinically isolated syndromes at presentation. J Neurol Neurosurg Psychiatry 2008;79:1236-44.
22. Batista S, Zivadinov R, Hoogs M, Bergsland N, Heininen-Brown M, Dwyer MG, Weinstock-Guttman B, Benedict RH. Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis. J Neurol 2012;259:139-46. [Research Support, Non-U.S. Gov't].
23. Sicotte NL, Kern KC, Giesser BS, Arshanapalli A, Schultz A, Montag M, Wang H, Bookheimer SY. Regional hippocampal atrophy in multiple sclerosis. Brain 2008;131:1134-41.
24. Benedict RH, Ramasamy D, Munschauer F, Weinstock-Guttman B, Zivadinov R. Memory impairment in multiple sclerosis: correlation with deep grey matter and mesial temporal atrophy. J Neurol Neurosurg Psychiatry 2009;80:201-6.
25. Amato MP, Bartolozzi ML, Zipoli V, Portaccio E, Mortilla M, Guidi L, Siracusa G, Sorbi S, Federico A, De SN. Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment. Neurology 2004;63:89-93.
26. Benedict RHB, Bruce JM, Dwyer MG, Abdelrahman N, Hussein S, Weinstock-Guttman B, Garg N, Munschauer F, Zivadinov R. Neocortical atrophy, third ventricular width, and cognitive dysfunciton in multiple sclerosis. Arch Neurol 2006;63:1301-6.
27. Smith A. Symbol Digit Modalities Test: Manual. Los Angeles: Western Psychological Services; 1982.
28. Benedict RH, Zivadinov R. Risk factors for and management of cognitive dysfunction in multiple sclerosis. Nat Rev Neurol 2011;7:332-42.
29. Feinstein A, Roy P, Lobaugh N, Feinstein K, O'Connor P, Black S. Structural brain abnormalities in multiple sclerosis patients with major depression. Neurology 2004;62:586-90.
30. Goldberg LR. The development of markers for the big-five factor structure. Psychol Assess 1992;4:26-42.
31. Goldberg LR. The structure of phenotypic personality traits. Am Psychol 1993;48:26-34.
32. McCrae RR, Costa PT. Validation of a five-factor model of personality across instruments and observers. J Pers Soc Psychol 1987;52:81-90.
33. McCrae RR, Stone SV, Fagan PJ, Costa PT. Identifying causes of disagreement between self-reports and spouse ratings of personality. J Pers 1998;66:285-313.
34. Marshall GN, Wortman CB, Vickers RR, Kusilas JW, Hervig LK. The five-factor model of personality as a framework for personality-health research. J Pers Soc Psychol 1994;67:278-86.
35. Chapman BP, Roberts B, Duberstein P. Personality and longevity: knowns, unknowns, and implications for public health and personalized medicine. J Aging Res 2011;2011:759170.
36. Chapman BP, Lyness JM, Duberstein P. Personality and medical illness burden among older adults in primary care. Psychosom Med 2007;69: 277-82.
37. De Fruyt F, Denollet J. Type D personality: a five-factor model perspective psychology and health. Psychol Health 2002;17:671-83.
38. Chapman B. Bandwidth and fidelity on the NEO Five-Factor Inventory: replicability and reliability of Saucier's (1998) item cluster subcomponents. J Pers Assess. 2007;88:220-34.
39. Duchek JM, Balota DA, Storandt M, Larsen R. The power of personality in discriminating between healthy aging and early-stage Alzheimer's disease. J Gerontol B Psychol Sci Soc Sci 2007;62:P353-61. [Research Support, N.I.H., Extramural].
40. Costa PT, McCrae RR. NEO PI-R Professional Manual. Odessa, FL: Psychological Assessment Resources, Inc; 1992.
41. Costa PT, McCrae RR. Professional Manual for the Revised NEO Personality Inventory and NEO Five-Factor Inventory. Odessa, FL: Psychological Assessment Resources, Inc.; 1992.
42. Schwartz ES, Chapman BP, Duberstein PR, Weinstock-Guttman B, Benedict RH. The NEO-FFI in multiple sclerosis: internal consistency, factorial validity, and correspondence between self and informant reports. Assessment 2011;18:39-49.
43. Petry S, Cummings JL, Hill MA, Shapira J, Petry S, Cummings JL, Hill MA, Shapira J. Personality alterations in dementia of the Alzheimer type. Arch Neurol 1988;45:1187-90. [Research Support, U.S. Gov't, Non-P.H.S.].
44. Strauss ME, Pasupathi M, Chatterjee A, Strauss ME, Pasupathi M, Chatterjee A. Concordance between observers in descriptions of personality change in Alzheimer's disease. Psychol Aging 1993;8:475-80. [Erratum appears in Psychol Aging 1994 Sep;9(3):413] [Comparative Study Research Support, U.S. Gov't, P.H.S.].
45. Siegler IC, Dawson DV, Welsh KA, Siegler IC, Dawson DV, Welsh KA. Caregiver ratings of personality change in Alzheimer's disease patients: a replication. Psychol Aging 1994;9:464-6. [Research Support, U.S. Gov't, P.H.S.].
46. Welleford EA, Harkins SW, Taylor JR. Personality change in dementia of the Alzheimer's type: relations to Caregiver Personality and Burden. Exp Aging Res 1995;21:295-314.
47. John OP, Robins RW. Determinants of interjudge agreement on personality traits: the big five domains, observability, evaluativeness, and the unique perspective of the self. J Pers. 1993;61:521-51.
48. Rankin KP, Baldwin E, Pace-Savitsky C, Kramer JH, Miller BL. Self awareness and personality change in dementia. J Neurol Neurosurg Psychiatry 2005;76:632-9 [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.].
49. Boyle LL, Lyness JM, Duberstein PR, Karuza J, King DA, Messing S, Tu X. Trait neuroticism, depression, and cognitive function in older primary care patients. Am J Geriatr Psychiatry 2010;18:305-12.
50. Chapman BP, Franks PF, Duberstein PR, Tindle H, Sink K, Robins J. Personality and cognitive functioning over seven years in older persons. Am J Geriatr Psychiatry 2012;20:612-21.
51. Weiss A, Sutin AR, Duberstein PR, Friedman B, Bagby RM, Costa PT Jr. The personality domains and styles of the five-factor model are related to incident depression in Medicare recipients aged 65 to 100. Am J Geriatr Psychiatry 2009;17:591-601.
52. Benedict RH, Priore RL, Miller C, Munschauer F, Jacobs L. Personality disorder in multiple sclerosis correlates with cognitive impairment. J Neuropsychiatry Clin Neurosci 2001;13:70-6.
53. Benedict RH, Hussein S, Englert J, Dwyer MG, Abdelrahman N, Cox JL, Munschauer FE, Weinstock-Guttman B, Zivadinov R. Cortical atrophy and personality in multiple sclerosis. Neuropsychology 2008;22:432-41.
54. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O'Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS. Diagnostic criteria for multiple sclerosis: 2005 revisions to the ''McDonald Criteria.'' Ann Neurol 2005;58:840-6.
55. Smith SM, Zhang Y, Jenkinson M, Chen J, Matthews PM, Federico A, De SN. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 2002;17:479-89.
56. Jenkinson M, Smith S. A global optimisation method for robust affine registration of brain images. Med Image Anal 2001;5:143-56. [Comparative Study Research Support, Non-U.S. Gov't].
57. Zhang Y, Brady M, Smith S. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging 2001;20:45-57. [Research Support, Non-U.S. Gov't].
58. Zivadinov R, Heininen-Brown M, Schirda CV, Poloni GU, Bergsland N, Magnano CR, Durfee J, Kennedy C, Carl E, Hagemeier J, Benedict RH, Weinstock-Guttman B, Dwyer MG. Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis: a case-control study. Neuroimage 2012;59:331-9.
59. Zivadinov R, Rudick RA, De Masi R, Nasuelli D, Ukmar M, Pozzi-Mucelli RS, Grop A, Cazzato G, Zorzon M. Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS. Neurology 2001;57:1239-47.
60. Zivadinov R, Weinstock-Guttman B, Benedict R, Tamano-Blanco M, Hussein S, Abdelrahman N, Durfee J, Ramanathan M. Preservation of gray matter volume in multiple sclerosis patients with the Met allele of the rs6265 (Val66Met) SNP of brain-derived neurotrophic factor. Hum Mol Genet 2007;16:2659-68.
61. Benedict RHB, Fischer JS, Archibald CJ, Arnett PA, Beatty WW, Bobholz J, Chelune G, Fisk JD, Langdon DW, Caruso LS, Foley FW, LaRocca NG, Vowels L, Weinstein A, DeLuca J, Rao SM, Munschauer FE. Minimal neuropsychological assessment of MS patients: a consensus approach. Clin Neuropsychol 2002;16:381-97.
62. Chiaravalloti ND, DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol 2008;7:1139-51.
63. Strober L, Englert J, Munschauer F, Weinstock-Guttman B, Rao S, Benedict RH. Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS. Mult Scler 2009; 15:1077-84.
64. Morrow SA, Drake AS, Zivadinov R, Munschauer F, Weinstock-Guttman B, Benedict RHB. Predicting loss of employment over three years in multiple sclerosis: clinically meaningful cognitive decline. Clin Neuropsychol 2010;24:1131-45.
65. Cummings JL. Vascular subcortical dementias: clinical aspects [review; 25 refs]. Dementia 1994;5:177-80.
66. Perrault A, Oremus M, Demers L, Vida S, Wolfson C. Review of outcome measurement instruments in Alzheimer's disease drug trials: psychometric properties of behavior and mood scales. J Geriatr Psychiatry Neurol 2000;13:181-96.
67. Mega MS, Dinov ID, Lee L, O'Connor SM, Masterman DM, Wilen B, Mishkin F, Toga AW, Cummings JL. Orbital and dorsolateral frontal perfusion defect associated with behavioral response to cholinesterase inhibitor therapy in Alzheimer's disease. J Neuropsychiatry Clin Neurosci 2000;12:209-18.
68. Litvan I, Mega MS, Cummings JL, Fairbanks L. Neuropsychiatric aspects of progressive supranuclear palsy. Neurology 1996;47:1184-9.
69. Litvan I, Paulsen JS, Mega MS, Cummings JL. Neuropsychiatric assessment of patients with hyperkinetic and hypokinetic movement disorders. Arch Neurol 1998;55:1313-9.
70. Mega MS, Cummings JL, O'Connor SM, Dinov ID, Reback E, Felix J, Masterman DL, Phelps ME, Small GW, Toga AW. Cognitive and metabolic responses to metrifonate therapy in Alzheimer disease. Neuropsychiatry Neuropsychol Behav Neurol 2001;14:63-8.
71. Diaz-Olavarrieta C, Cummings JL, Velazquez J, Cadena CG. Neuropsychi-atric manifestations of multiple sclerosis. J Neuropsychiatry Clin Neurosci 1999;11:51-7.
72. Fishman I, Benedict RHB, Bakshi R, Priore R, Weinstock-Guttman B. Construct validity and frequency of euphoria sclerotica in multiple sclerosis. J Neuropsychiatry Clin Neurosci. 2004;16:350-6.
73. Mega MS, Masterman DM, O'Connor SM, Barclay TR, Cummings JL. The spectrum of behavioral responses to cholinesterase inhibitor therapy in Alzheimer disease. Arch Neurol 1999;56:1388-93.
74. Tekin S, Mega MS, Masterman DM, Chow T, Garakian J, Vinters HV, Cummings JL. Orbitofrontal and anterior cingulate cortex neurofibrillary tangle burden is associated with agitation in Alzheimer disease. Ann Neurol 2001;49:355-61.
75. Bridgeford D, Arciniegas DB, Batkis M, Sandberg E, Beresford TP. Methylphenidate treatment of neuropsychiatric symptoms of central and extrapontine myelinolysis. J Stud Alcohol 2000;61:657-60.
76. McKeith I, Del Ser T, Spano P, Emre M, Wesnes K, Anand R, Cicin-Sain A, Ferrara R, Spiegel R. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet 2000;356:2031-6.
77. Street JS, Clark WS, Gannon KS, Cummings JL, Bymaster FP, Tamura RN, Mitan SJ, Kadam DL, Sanger TM, Feldman PD, Tollefson GD, Breier A. Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group. Arch Gen Psychiatry 2000;57:968-76.
78. Figved N, Benedict R, Klevan G, Myhr KM, Nyland HI, Landro NI, Larsen JP, Aarsland D. Relationship of cognitive impairment to psychiatric symptoms in multiple sclerosis. Mult Scler 2008;14:1084-90.
79. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 1986;51:1173-82.
80. Langdon DW. Cognition in multiple sclerosis. Curr Opin Neurol 2011; 24:244-9.
81. Mangold DL, Wand GS. Cortisol and adrenocorticotropic hormone responses to naloxone in subjects with high and low neuroticism. Biol Psychiatry 2006;60:850-5. [Clinical Trial Research Support, N.I.H., Extramural].
82. Wilson RS, Arnold SE, Schneider JA, Li Y, Bennett DA. Chronic distress, age-related neuropathology, and late-life dementia. Psychosom Med 2007;69:47-53. [Research Support, N.I.H., Extramural].
83. Benedict RE. Quality medical homes: meeting children's needs for therapeutic and supportive services. Pediatrics 2008;121:e127-34.
84. Rabins PV. Euphoria in multiple sclerosis. In: Ral SM, editor. Neurobehavioral Aspects of MS. New York City: Oxford University Press; 1990:180-5.
85. Strober LB, Christodoulou C, Benedict RH, Westervelt HJ, Melville P, Scherl WF, Weinstock-Guttman B, Rizvi S, Goodman AD, Krupp LB. Unemployment in multiple sclerosis: the contribution of personality and disease. Mult Scler 2012;18:647-53.
86. Houtchens MK, Benedict RH, Killiany R, Sharma J, Jaisani Z, Singh B, Weinstock-Guttman B, Guttmann CR, Bakshi R. Thalamic atrophy and cognition in multiple sclerosis. Neurology 2007;69:1213-23.